drugset / Trial / NCT04477369
Safety and Pharmacokinetics of DWJ1439, DWJ1464, DWC202003 or DWC202004 in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to explore the differences in pharmacokinetics and safety characteristics between Test Drugs(DWJ1439, DWJ1464) and that of Reference Drugs(DWC202003, DWC202004) in healthy adults.
Timeline
- Start
- 2020-08-06
- Primary completion
- 2020-08-31
- Completion
- 2020-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DWC202003 | Unknown | 300 mg | Oral |
| Subject | DWC202004 | Unknown | 300 mg | Oral |
| Subject | DWJ1439 | Unknown | 300 mg | Oral |
| Subject | DWJ1464 | Unknown | 300 mg | Oral |
Indications
No indication recorded.